MTOR and metabolic dysfunction-associated steatotic liver disease: Liu et al. have further identified the long ncRNA (lncRNA) SNHG6 as an enhancer of cholesterol-dependent mTORC1 lysosomal recruitment and activator of FAF2-mTOR interaction at ER-lysosome contacts, which increased progression from NAFLD to HCC [148].